GADOTERIC ACID , PARACETAMOL , coramitug, CETIRIZINE , SODIUM CHLORIDE
NN6019-7565
Phase 2 small_molecule active
Quick answer
GADOTERIC ACID , PARACETAMOL , coramitug, CETIRIZINE , SODIUM CHLORIDE for Participants with transthyretin amyloid cardiomyopathy (ATTR CM) is a Phase 2 program (small_molecule) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Participants with transthyretin amyloid cardiomyopathy (ATTR CM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active